Literature DB >> 4635498

Host-parasite relationships in experimental Streptobacillus moniliformis arthritis in mice.

N L Savage.   

Abstract

Several variables of host and parasite, relating to the establishment of the chronic Streptobacillus moniliformis-induced arthritis, were studied. Results from these studies indicated (i) that intravenous inoculation of the organism produced a progressive bacteremia and a polyarthritis, whereas subcutaneous inoculation into the top of the back foot produced an intermittent bacteremia and arthritis only in that foot, (ii) that serum-broth-grown cells were more virulent than serum-agar-grown cells, (iii) that young animals were more susceptible to infection than old, and (iv) that the organism apparently had a predilection for joints. It was also determined that the leukocyte and antibody responses of mice to infection were minimal with a slight neutrophilia and a maximum antibody titer of 1:640 detected after infection. Measurements of the effectiveness of antibody and leukocytes in prevention or resolution of infection indicated (i) that the presence of homologous antibody prior to infection prolonged the incubation period for development of the lesion, (ii) that the opsonic index was 1.2 to 1.4, and (iii) that the organism was apparently resistant to destruction by in vitro phagocytosis and actually increased in number in the presence of phagocytes. It was concluded that these represented some of the prime factors contributing to the establishment of the infection and its chronicity.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4635498      PMCID: PMC422346          DOI: 10.1128/iai.5.2.183-190.1972

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  10 in total

1.  The pathogenesis of mycoplasma (PPLO) arthritis in rats.

Authors:  J R WARD; R S JONES
Journal:  Arthritis Rheum       Date:  1962-04

2.  Arthritis caused by Streptobacillus moniliformis and pleuropneumonialike organisms in small rodents.

Authors:  E A FREUNDT
Journal:  Lab Invest       Date:  1959 Nov-Dec       Impact factor: 5.662

3.  The pathogenesis of bone and joint infection produced in rats by Streptobacillus moniliformis.

Authors:  E M LERNER; L SOKOLOFF
Journal:  AMA Arch Pathol       Date:  1959-04

4.  Experimental infection of rats with Streptobacillus moniliformis.

Authors:  E M LERNER; E SILVERSTEIN
Journal:  Science       Date:  1957-08-02       Impact factor: 47.728

5.  Streptobacillus moniliformis infection in mice.

Authors:  E A FREUNDT
Journal:  Acta Pathol Microbiol Scand       Date:  1956

6.  Experimental investigations into the pathogenicity of the L-phase variant of Streptobacillus moniliformis.

Authors:  E A FREUNDT
Journal:  Acta Pathol Microbiol Scand       Date:  1956

7.  Arthritis in rats produced by pleuro-pneumonia-like organisms.

Authors:  M W PARKES; F WRIGLEY; B O'BRIEN
Journal:  Ann Rheum Dis       Date:  1951-06       Impact factor: 19.103

8.  Physiology of aging leukocytes. I. Phagocytosis and transformation.

Authors:  J M Aune; N J Wade
Journal:  Proc Soc Exp Biol Med       Date:  1970-06

9.  Role of Biological Mimicry in the Pathogenesis of Rat Arthritis Induced by Mycoplasma arthritidis.

Authors:  J F Cahill; B C Cole; B B Wiley; J R Ward
Journal:  Infect Immun       Date:  1971-01       Impact factor: 3.441

10.  Immunological responses of the rat to Mycoplasma arthritidis.

Authors:  B C Cole; J F Cahill; B B Wiley; J R Ward
Journal:  J Bacteriol       Date:  1969-06       Impact factor: 3.490

  10 in total
  2 in total

Review 1.  Approved and novel strategies in diagnostics of rat bite fever and other Streptobacillus infections in humans and animals.

Authors:  Tobias Eisenberg; Christa Ewers; Jörg Rau; Valerij Akimkin; Werner Nicklas
Journal:  Virulence       Date:  2016-04-18       Impact factor: 5.882

2.  Clinical microbiological, and histological manifestations of Streptobacillus moniliformis-induced arthritis in mice.

Authors:  N L Savage; G N Joiner; D W Florey
Journal:  Infect Immun       Date:  1981-11       Impact factor: 3.441

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.